Why the study?
The review aimed to highlight the genetic and molecular underpinnings of mitochondrial cardiomyopathy, which arises from mutations in mitochondrial DNA or nuclear genes affecting mitochondrial function.
Answers are grounded in this paper and cite their sources.
This review summarizes the genetic and molecular mechanisms underlying mitochondrial cardiomyopathy, providing an update on diagnostic challenges and potential future therapies.
Mitochondrial cardiomyopathy is a rare specific myocardial condition characterized by abnormal myocardium structure and/or function due to mitochondrial respiratory chain deficiency. This cardiac disorder results from mutations in mitochondrial DNA or nuclear genes affecting mitochondrial function. These mutations disrupt oxidative phosphorylation and consequently lead to energy deficit in the myocardial tissue and systemic symptoms due to impaired mitochondrial metabolism. In the current review, we aimed to highlight genetic and molecular underpinnings of mitochondrial cardiomyopathy. The impact of mitochondrial DNA characteristics on mitochondrial cardiomyopathy, mutations in both mitochondrial and nuclear genomes, as well as diagnostic limitations and future therapies, will be presented in this work.
No takes yet. Share an insight, caveat, or question.
Moudian et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: